Suchergebnisse - "Sarilumab"

PubPharm (72)

1

IL-6-induced response of human osteoblasts from patients with rheumatoid arthritis after inhibition of the signaling pathway

enthalten in: Clinical and experimental medicine | 2023

von Sellin, M. | Klinder, A. | Bergschmidt, P. | +2

2

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

enthalten in: Arthritis research & therapy | 2023

von Schmidt, W. | Dasgupta, B. | Sloane, J. | +13

3

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

enthalten in: Arthritis Research & Therapy | 2023

von Schmidt, W. | Dasgupta, B. | Sloane, J. | +13

4

Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper

enthalten in: The New England journal of medicine | 2023

von Spiera, R. | Unizony, S. | Warrington, K. | +115

5

Rheumatoid neutrophilic dermatosis under treatment with the interleukin-6-receptor-antagonist sarilumab in a patient with seropositive rheumatoid arthritis

enthalten in: Journal of cutaneous pathology | 2023

von Jost, M. | Schwarz, T. | Wehkamp, U. | +2

6

A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis

enthalten in: Rheumatology (Oxford, England) | 2023

von Baker, M. | Horomanski, A. | Wang, Y. | +7

7

Differences in the strength of inhibition of interleukin-6 signalling by subcutaneous sarilumab and tocilizumab in rheumatoid arthritis patients

enthalten in: Clinical and experimental rheumatology | 2023

von Saito, S. | Suzuki, K. | Yoshimoto, K. | +5

8

Disproportionate articular pain is a frequent phenomenon in rheumatoid arthritis and responds to treatment with sarilumab

enthalten in: Rheumatology (Oxford, England) | 2023

von Choy, E. | Bykerk, V. | Lee, Y. | +6

9

Interleukin-6 and Macular Edema : A Review of Outcomes with Inhibition

enthalten in: International journal of molecular sciences | 2023

von Yang, J. | Goldberg, D. | Sobrin, L.

10

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

in: Arthritis Research & Therapy | 2023

von Wolfgang A. Schmidt | Bhaskar Dasgupta | Jennifer Sloane | +13

1
2
3
4
5
6
7
8
Nächster »
[8]